Nanofat injection for male and female pattern hair loss
Treatments studied
Part of Skin clinical trials.
This trial tests whether injecting nanofat (a processed, finely minced fat tissue from your own body) into the scalp can help regrow hair in people with common pattern hair loss (androgenetic alopecia). The goal is to improve hair density and thickness without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have a confirmed diagnosis of androgenetic alopecia (common pattern hair loss) seen by a doctor with a special skin-scope.
- You have not used any topical hair loss treatments (like creams or lotions) for at least the past 3 months.
- You do not have total body hair loss, scarring hair loss, or hair loss from other medical conditions.
- You have no skin disease or active infection on the scalp.
- You are not allergic to any of the treatment components.
- You have not used any hair loss treatments (topical or oral) in the last 3 months.
- You are not pregnant or breastfeeding.
- You have no history of raised or thick scars (keloids).
- Your hair loss is not in the most severe stages (not stage 6 or 7 on the Hamilton-Norwood scale, not stage 3 on the Ludwig scale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments, Botox injections and nanofat injections, to see which works better for male pattern baldness. If you have mild hair loss, this study might help you understand which approach offers better results.
This study tests whether microneedling (a procedure using tiny needles on the scalp) can safely help regrow hair in men with male pattern baldness. Participants will receive the procedure and be monitored over time with scalp photos.
This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.
This trial compares two treatments—secretome and platelet-rich plasma (PRP)—to see which helps grow thicker, denser hair in people with genetic hair loss (androgenetic alopecia). It's for adults aged 25 to 59 who have stopped taking certain hair loss medications for at least a month.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.